← SynDRA

GANDOTINIB

SynDRA canonical compound SYN0033268 — structure-anchored drug synonym record

All known targets

• JAK2
• JAK3

Mechanisms of action (all sources)

• JAK2 INHIBITOR
• Tyrosine-protein kinase JAK2 inhibitor
• JAK3 INHIBITOR
• JAK inhibitor
• JAK2 MODULATOR

Cross-references

• PubChem CID: 46213929
• ChEMBL: CHEMBL2107823
• DrugBank: DB13040
• ChEBI: 188757
• KEGG: D10365
• PDB: QQC
• Wikipedia: Gandotinib
• TTD: D05TSJ
• LINCS BRD: BRD-K25630527

Synonyms

• LY-2784544
• LY2784544
• GANDOTINIB (LY2784544)
• Gandotinib (LY2784544)
• UNII-ANC71R916O
• LY2784544(Gandotinib)
• ANC71R916O
• 3-(4-chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholinomethyl)imidazo[1,2-b]pyridazin-6-amine
• C23H25ClFN7O
• 3-[(4-Chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)imidazo[1,2-b]pyridazin-6-amine
• 3-(4-chloro-2-fluorobenzyl)-2-methyl-N-(3-methyl-1H-pyrazol-5-yl)-8-(morpholinomethyl)imidazo[1,2-b]pyridazin-6-amine
• Gandotinib [USAN]
• Gandotinib(LY2784544)
• Gandotinib (USAN)
• 3-((4-Chloro-2-fluorophenyl)methyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8- (morpholin-4-ylmethyl)imidazo(1,2-b)pyridazin-6-amine
• 3-(4-Chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8- (morpholinomethyl)imidazo(1,2-b)pyridazin-6-amine
• 3-[(4-chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholin-4-ylmethyl)imidazo[1,2-b]pyridazin-6-amine
• Imidazo(1,2-b)pyridazin-6-amine, 3-((4-chloro-2-fluorophenyl)methyl)-2-methyl-N-(5- methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)-
• Gandotinib [USAN:INN]
• GANDOTINIB [INN]
• LY2784544;Gandotinib
• GANDOTINIB [WHO-DD]
• Gandotinib; LY2784544
• GTPL7909
• SCHEMBL2513132
• CHEMBL2107823
• SCHEMBL15458955
• DTXSID20153789
• CHEBI:188757
• HMS3655L06
• HMS3750I09
• BCP02309
• EX-A1114
• MFCD20482143
• NSC764820
• s2179
• ZINC68245097
• AKOS026673949